About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Infection and Immunity in pediatric patients research group is a multidisciplinary pediatric research group made up of health professionals involved in translational research in the field of pediatric infectious diseases and immunodeficiencies, two related fields in terms of pathophysiology and clinical implications. It is a consolidated research group recognized by the AGAUR and is the only one with the accreditation of the Jeffrey Modell Foundation in research in the field of primary immunodeficiencies throughout the state.
The group was officially created in 2010, belongs to the area of Infectious Diseases and participates in the transversal programs of Advanced Translational Immunology and Rare Diseases and actively participates in national and international competitive projects, carries out multiple academic and industry-linked clinical trials and has increased the number and quality in recent years. In addition, it has its own laboratory specially dedicated to advanced immune studies.
IP: Pere Soler Palacín Collaborators: Marina García Prat, Laura Batlle Masó Funding agency: EUROPEAN COMMISSION Funding: 163667.5 Reference: UNDINE_HE-HLTH-DISEASE21 Duration: 01/06/2022 - 31/05/2026
PMID: 37131861 Journal: The Lancet regional health. Europe Year: 2023 Reference: Lancet Reg Health Eur. 2023 May;28:100613. doi: 10.1016/j.lanepe.2023.100613. Epub 2023 Apr 14. Impact factor: Publication type: Paper in international publication Authors: Alvarez-Mon, Melchor; Anagua, Jesse Omar; Arana-Arri, Eunate; Arribas, Jose R; Bailon, Lucia; Barreiro, Antonio; Benet, Susana; Blanch-Lombarte, Oscar; Blanco, Julia; Borobia, Alberto M et al. DOI: 10.1016/j.lanepe.2023.100613
PMID: 37863310 Journal: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES Year: 2023 Reference: Int J Infect Dis. 2023 Oct 18:S1201-9712(23)00749-X. doi: 10.1016/j.ijid.2023.10.013. Impact factor: Publication type: Paper in international publication Authors: Abu-Zeinah, Ghaith; Adzic-Vukicevic, Tatjana; Aiello, Tommaso Francesco; Ammatuna, Emanuele; Arellano, Elena; Barac, Aleksandra; Bavastro, Martina; Bergantim, Rui; Besson, Caroline; Biernat, Monika M et al. DOI: 10.1016/j.ijid.2023.10.013
PMID: 37877732 Journal: Pediatric pulmonology Year: 2023 Reference: Pediatr Pulmonol. 2023 Oct 25. doi: 10.1002/ppul.26736. Impact factor: Publication type: Other (letters to the editor, abstracts, corrigendum, etc.) Authors: Alonso, Lucia; Bordas, Anna; Casabona, Jordi; Castells-Sanchez, Alba; Colom-Cadena, Andreu; Dacosta-Aguayo, Rosalia; Dimitriadis, Stavros I; Ganem, Fabiana; Garcia-Molina, Alberto; Gascon, Mireia et al. DOI: 10.1002/ppul.26736
PMID: 37876937 Journal: Frontiers in Immunology Year: 2023 Reference: Front Immunol. 2023 Oct 9;14:1279171. doi: 10.3389/fimmu.2023.1279171. eCollection 2023. Impact factor: Publication type: Paper in international publication Authors: Acuna Perez, Maria Jose; Bai, Yuxian; Bhagia, Pooja; Bilici, Mehmet; Calavia, Olga; Chung, Hyun Cheol; Colobran, Roger; Garcia Ramos, Maite; Garcia-Aznar, Jose Maria; Janjigian, Yelena Y et al. DOI: 10.3389/fimmu.2023.1279171
PMID: 35305952 Journal: ANALES DE PEDIATRIA Year: 2022 Reference: An Pediatr (Engl Ed). 2022 Apr;96(4):357-359. doi: 10.1016/j.anpede.2021.01.008. Epub 2022 Mar 3. Impact factor: 1.5 Publication type: Letter whit IF Authors: Bassets-Bosch, Alba, Raya-Munoz, Judith, Worner-Tomasa, Nuria, Melendo-Perez, Susana, Gonzalez-Peris, Sebastia et al. DOI: 10.1016/j.anpede.2021.01.008
PMID: 34571020 Journal: JOURNAL OF PEDIATRICS Year: 2022 Reference: J Pediatr. 2022 Feb;241:126-132.e3. doi: 10.1016/j.jpeds.2021.09.029. Epub 2021 Sep 25. Impact factor: 4.406 Publication type: Paper in international publication Authors: Perez, Seoane B, Tagarro, A, Sanz-Santaeufemia, F J, Grasa, C, Cobos, E, Yebra, J, Alonso-Cadenas, J A, Baquero-Artigao, F, Mesa, Guzman Jm, Reinoso, T et al. DOI: 10.1016/j.jpeds.2021.09.029
PMID: 33991581 Journal: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY Year: 2022 Reference: J Allergy Clin Immunol. 2022 Jan;149(1):369-378. doi: 10.1016/j.jaci.2021.04.033. Epub 2021 May 12. Impact factor: 10.793 Publication type: Paper in international publication Authors: Riviere, Jacques G, van der Burg, Mirjam, Gattorno, Marco, Seidel, Markus G, Burns, Siobhan, Warnatz, Klaus, Hauck, Fabian, Brogan, Paul, Gilmour, Kimberly C, Schuetz, Catharina et al. DOI: 10.1016/j.jaci.2021.04.033
PMID: 32117230 Journal: Frontiers in Immunology Year: 2020 Reference: Front Immunol. 2020 Feb 12;11:46. doi: 10.3389/fimmu.2020.00046. eCollection 2020. Impact factor: 5.085 Publication type: Paper in international publication Authors: Riviere, Jacques G, Franco-Jarava, Clara, Martinez-Gallo, Monica, Aguilo-Cucurull, Aina, Blasco-Perez, Laura, Paramonov, Ida, Antolin, Maria, Martin-Nalda, Andrea, Soler-Palacin, Pere, Colobran, Roger et al. DOI: 10.3389/fimmu.2020.00046
PMID: 32076423 Journal: Frontiers in Immunology Year: 2020 Reference: Front Immunol. 2020 Jan 31;11:107. doi: 10.3389/fimmu.2020.00107. eCollection 2020. Impact factor: 5.085 Publication type: Paper in international publication Authors: Vinas-Gimenez, Laura, Padilla, Natalia, Batlle-Maso, Laura, Casals, Ferran, Riviere, Jacques G, Martinez-Gallo, Monica, de la Cruz, Xavier, Colobran, Roger et al. DOI: 10.3389/fimmu.2020.00107
The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.
The study, which is part of the European RECOMB project, is currently recruiting volunteers.
This clinical trial is part of the European project RBDCOV, led by HIPRA in which Vall d'Hebron participates, whose recruitment is still open.
